Home » Note to Readers

Note to Readers

Aug 25, 2011
Premium

Gene Silencing News will be on hiatus next week and will not publish on Thursday, Sept. 1. The next issue of the newsletter will go out to subscribers on Thursday, Sept. 7.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Years and Years

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Diving Evolution

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

This Week in Science

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

Issues to Overcome

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

May
08
Featured Webinar

Structural Variation Detection by Proximity Ligation from FFPE Tumor Tissue

Sponsored by
Dovetail Genomics

This webinar will discuss a proximity ligation-based method for studying structural variation in formalin-fixed paraffin-embedded (FFPE) tissue.

What's Popular?

In Gene Silencing/Gene Editing

  1. Taconic Biosciences Licenses Easi-CRISPR Tech

  2. Chemotherapy Resistance Pathway for AML Identified in CRISPRa Screen

  3. Bioinformatics Pipeline Annotates CRISPR Repeats, Cas Genes; Assembles Data in One Repository

    Premium

  4. Researchers Identify Essential Genes for Pluripotent Stem Cells Through CRISPR-Cas9 Screening

  5. Chemotherapy Resistance Pathway for AML Identified in CRISPRa Screen

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.